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Abstract: Three women were consecutively admitted to our medical intensive care unit for 
thyrotoxicosis after the ingestion of dietary pills accidentally containing high levels of thyroxin. 
These cases were observed during an outbreak in the Paris area. Despite similar blood levels 
of thyroid hormones, their clinical presentation and outcome were very different. One patient 
developed febrile confusion and died from malignant hyperthermia. The second one had progres-
sive confusion requiring mechanical plasma exchange therapy and had a favorable outcome. 
The third one had very moderate symptoms. These exceptional observations raise several issues 
concerning diagnosis, physiopathology and treatment of thyrotoxicosis factitia.
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Patient 1
A 57-year-old woman was admitted to our Medical Intensive Care Unit (MICU) 
for shock, coma and high fever. She had no relevant medical history but was taking 
spironolactone, metformin, doxylamine and “homeopathic pills”. Her weight was 
77 kg and height 176 cm. Ten days before admission, the patient reported headache. 
Three days before admission in our MICU, she became confused. Next day, she 
was referred to the emergency department of another hospital (hour 0, H0). She was 
disorientated and agitated without neurological abnormalities. Blood pressure was 
190/90 mmHg, pulse, 146 beats per minute and temperature, 38 °C. Brain CT scan 
and CSF analysis were normal. She was given 100 mg of intravenous loxipamine 
(H2), aciclovir, ceftriaxone and amoxicillin and was admitted to the medical ward. As 
cultures of blood, urine and CSF were negative, and the C-reactive protein value was 
normal, anti-infective therapies were discontinued. However, the temperature remained 
high (39.2 °C, H24) despite acetaminophen. Because of increasing agitation she was 
given 100 mg of intravenous tiapride at H14 and H32. Her consciousness afterwards 
deteriorated (Glasgow Coma Scale GCS = 4) and she became hypotensive. She received 
ﬂ  uid loading (normal saline), norepinephrine, and the trachea was intubated. Whole 
body CT scan showed no abnormalities. The patient was then referred to our MICU 
(H40). She had severe circulatory failure, with diffuse mottling, oliguria and a mean 
blood pressure of 70 mmHg while receiving 1.5 μg/kg/min norepinephrine. Central 
body temperature was 40.9 °C (Figure 1). Room temperature was 20 °C. Transtho-
racic echocardiography showed a hyperkinetic heart but no other abnormality. On 
admission, blood test results were: sodium: 154 mmol/L, bicarbonates: 16 mmol/L, 
chloride: 125 mmol/L, lactates: 3 mmol/L, creatine kinase: 588 IU/L , creatininaemia 
76 μmol/L. Blood gas analysis showed pH: 7.33, PaO2: 229 mmHg while under a 75% 
inspired fraction of oxygen and PaCO2: 32 mmHg. Total blood count was normal, 
prothrombin time, 47%, coagulation factor V, 62% and ﬁ  brinogen, 6.2 g/L. Serum 
toxic screening with mass spectrography was negative. Hydrocortisone (100 mg 
3 times a day) was started (a later report showed that cortisol level was normal). Therapeutics and Clinical Risk Management 2008:4(6) 1376
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Although there was no documented bacterial infection, 
vancomycin, cefotaxime and gentamicin were started. 
Because the patient’s body temperature rose to 42.3 °C at 
H48 despite external cooling, hemodialysis was performed 
with a dialysate temperature of 33 °C. There was no muscular 
rigidity. The patient’s temperature went down to 38.2 °C 
by the end of dialysis (H56). However, circulatory failure 
worsened and epinephrine was administered because of 
left ventricle hypokinesia (H62). Hemodialysis was again 
started because of symptomatic hyperkaliemia (8 mmol/L, 
H66) related to massive rhabdomyolysis. The patient died 
of refractory shock, 43 hours after MICU admission (H84). 
Two days later, the French health authorities issued a mes-
sage warning against the toxicity of “dietary pills”, which 
had been manually prepared in one particular pharmacy 
and contained huge amount of thyroxin. It turned out that 
these “dietary pills” were the “homeopathic pills” taken by 
our patient. Analysis of blood drawn on MICU admission 
conﬁ  rmed hyperthyroidism (Table 1).
Patient 2
A 71-year-old previously healthy woman was admitted to 
our MICU 5 days after admission of Patient one for severe 
thyrotoxicosis. She had a history of depression and had been 
treated for 1 year with similar “dietary pills”. Her free T4 
and TSH levels were normal in 6 months before. One week 
before admission, she reported fatigue, headache, myalgia, 
palpitations and fever. She stopped the dietary pills. The 
day of admission, mild confusion occurred. The patient 
was contacted by health authorities as a patient who had 
been prescribed the suspectedly toxic “dietary pills”. She 
was referred to our institution (day 0, D0) because of high 
levels of serum thyroid hormone (Table 1). The patient was 
awake but severely confused. She had no chills, sweating, 
jaundice or neck rigidity. Blood pressure was 130/60 and 
body temperature was 37 °C. Except for tachyarrhyth-
mia, cardio-pulmonary examination was normal. ECG 
revealed atrial ﬁ  brillation. The patient was given 40 mg oral 
propranolol 4 times a day, 100 mg hydrocortisone 3 times a 
day, cholestyramine 3 times a day, and was given 4 tablets of 
propylthiouracyl 4 times a day for 24 hours and subcutane-
ous heparin. On D3, she was unable to speak and severely 
agitated. No muscular rigidity was observed. Because of 
clinical degradation and high plasma thyroid hormone levels, 
plasma exchange (PE) therapy was performed on D3 with 
1.5l of 4% albumin and 1.5 L of hydroxy-ethyl-amidon, and 
repeated on D4 with the addition of 1L fresh frozen plasma 
(Figure 2). After a second PE, the patient was placed on a 
ventilator because of impaired consciousness (GCS: 7). An 
EEG did not reveal any features of epilepsy. A CT scan of the 
head was normal. The thyroid hormone levels slowly returned 
to close to normal, the patient’s consciousness gradually 
improved. She was extubated on D10. She experienced a 
perfect cognitive recovery but exhibited ﬂ  accid tetraparesia. 
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Figure 1 Time course and events of the evolution of Patient one during her stay in the ﬁ  rst hospital (admission in the Emergency Room [ER] and referral to the ward) and 
in our hospital (admission in the ER and then in Intensive Care Unit (ICU]). Red arrows indicate main events, grey areas represent sustained therapy. The blue diagram depicts 
temperature evolution. The plasma creatine phosphokinase (CPK) are in red at the top of the ﬁ  gure.Therapeutics and Clinical Risk Management 2008:4(6) 1377
Thyrotoxicosis outbreak due to dietary pills
An electromyogram conﬁ  rmed myoneurogen abnormalities. 
On D25 she was referred to a rehabilitation facility for 
persistent inability to stand up and walk alone.
Patient 3
A 40-year-old woman was admitted to our MICU 5 days after 
the admission of Patient two (day 0, D0) for thyrotoxicosis. 
Her medical history was uneventful. She had been overweight 
(94 kg, 165 cm), and had taken the “dietary pills”, since 
2004. Three weeks before admission, she started complaining 
of asthenia, myalgia, headache, sweating, tremor of the 
lower limbs and dyspnea. She spontaneously stopped the 
pills 6 days before admission. She heard about the toxicity 
of the pills through the media and went to the emergency 
department of our hospital. On admission, physical examina-
tion was normal except sinusal tachycardia (113 beats/min). 
Echocardiography and EEG were unremarkable. She was 
admitted to the MICU for monitoring and was treated with 
40 mg oral propranolol 4 times a day, cholestyramine 3 times 
a day and 100 mg intravenous hydrocortisone 3 times a day. 
The thyroid hormone levels measured at D1 showed hyper-
thyroidism (Table 1). On the same day the patient was agitated 
and was given 100 mg oral clorazepate. She improved and 
was referred to the endocrinology department on D4. She had 
then an uneventful follow-up. At D10, her thyroid hormone 
levels were still high : TSH = 0.03 mIU/L (0.15–3.7), total 
T4  = 264 pmol/L (80–160), free T4 = 66.5 pmol/L (7.5–21.1) 
and free T3 = 9 pmol/L (3.6–7).
Methods
Written informed consent to publication of the present 
reports was obtained from each patient or from their closest 
relatives. Thyroid tests were performed using the following 
methods: TSH, Access US hTSH (Beckman Coulter), normal 
range : 0.15–3.7 mIU/L; Unbound tri-iodothyronine, Access 
Free T3 (Beckman Coulter), normal range : 3.6–7.0 pmol/L; 
Unbound Thyroxin, Access Free T4 (Beckman Coulter), 
normal range: 7.5–21.0 pmol/L; Total Thyroxin, Access 
Table 1 Levels of blood thyroid hormones in the three patients on admission to intensive care unit
Thyroid hormone normal patient 1 patient 2 patient 3
Total T4 (pmol/L) [80–160] 404 469 631
Free T4 (pmol/L) [7.5–21.1] 75 75 75
Free T3 (pmol/L) [3.6–7] 45 45 45
TSH (mU/L) [0.15–3.7] 0 0 0.02
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Figure 2 Serum thyroxin (T4) and thyroxine-binding globulin (TBG) before and after plasma exchange (PE) therapy in Patient 2. Total plasma T4 evolution is represented by 
vertical grey bars, free T4 evolution is written in the grey area at the top of the diagram.Therapeutics and Clinical Risk Management 2008:4(6) 1378
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total T4 (Beckman Coulter) normal range: 75–160 mol/L; 
Thyroid-Binding Globulin, RIA-gnost TBG (CISbio Interna-
tional), normal range (non-pregnant adults): 10–42 mg/L.
Discussion
Thyrotoxicosis factitia is the intentional or inadvertent 
ingestion of thyroid hormones in excess. It has been described 
as a complication of an inappropriate substitutive therapy, 
in the course of a non indicated L-thyroxin treatment for 
obesity (Yoon et al 2003), following the ingestion of beef 
contaminated with thyroid gland (Parmar and Sturge 2003) 
and after accidental ingestion (Bhasin et al 1981). Treatment 
of thyrotoxicosis facticia should include the discontinuation 
of intoxication, gastric lavage in the case of acute inges-
tion, ß blockers, digoxin or hydrocortisone to counteract 
the action of thyroid hormones and/or reduce the conver-
sion of T4 to T3. There is no need for treatments aimed at 
suppressing endogenous thyroid hormones production such 
as neomercazole, radioiodine, or thyroidectomy. Plasma 
exchange therapy is advocated for life-threatening condi-
tions (Binimelis et al 1987; Kokuho et al 2004), because 
it has been shown to remove 25% to 30% of the hormones 
ingested. Sodium ipodate, used for oral cholecystography, 
has been recommended because it inhibits the type I iodo-
thyronine 5’-monodeiodinase which catalyses the T4 to T3 
conversion.
Our cases can be classiﬁ  ed as both a complication of 
treatment for obesity and as accidental thyroxine ingestion. 
The “dietary pills” were ordered by the same practitioner 
for the treatment of obesity, prepared by the same pharmacy 
and labelled “phytotherapy-homeopathy”. Each pill usually 
contained thyroid compounds, caffeine, carrageenan, sibutra-
mine, and infra-therapeutic doses of L-thyroxine (25 μg), 
diazepam, aminophylline and metformin. All three patients 
had taken these pills for months or years. A toxicological 
investigation revealed that 30 mg of L-thyroxin had been 
put into each of the pills responsible for the poisoning. In 
addition to our patients, 34 other women were identiﬁ  ed as 
having taken those pills sold during 4 days. Fifteen of them 
were admitted to hospital and 9 of them to ICU. None of these 
patients died. An outbreak of thyrotoxicosis due to errors 
in the preparation of pharmaceutical agents was reported 
20 years ago in Spain among patients on substitutive therapy 
for thyroid disease (Binimelis et al 1987).
Despite a fulminant presentation, thyroid storm was not 
diagnosed in patient 1. Her practitioner’s prescription was 
illegible, and the patient’s family reported that she was taking 
“homeopathy” to lose weight. The initial encephalitis-like 
initial presentation followed by multi-organ failure made 
hyperthyroidism difﬁ  cult to diagnose. The skin was neither 
moist nor warm. No tremor or sweating were noted. Although 
these signs are usually reported during thyroid storm, they 
may be absent in cases of severe dehydration. Confusion 
and occasionally coma have been observed in thyroid storm 
(Newmark et al 1974; Howton 1988; Tietgens and Leinung 
1995), but their association with high fever is ﬁ  rst of all 
suggestive of an infectious disease. This implies that in case 
of a critically ill patient said to be on weight reduction, the 
possibility of thyroid hormone ingestion should be considered 
(Braunstein et al 1986). Rhabdomyolysis has been observed 
during thyroid crisis (Bennett and Huston 1984; Hosojima 
et al 1992) but it never reached the magnitude observed in 
patient 1. Hyperthermia is common during thyroid storm 
(Simon 1986; Tietgens and Leinung 1995). Nevertheless 
extreme fever (more than 42 °C) associated with rhabdomy-
olysis is much more suggestive of heat stroke or malignant 
hyperthermia (Caroff and Mann 1993). Combined with 
the increased heat production due to hyperthyroidism, the 
neuroleptic agents might have enhanced the failure of ther-
moregulation. Several reports of malignant hyperthermia-
like pictures in patients with hyperthyroidism receiving 
general anesthesia (Murray 1978; Stevens 1983; Bennett 
and Wainwright 1989) support this hypothesis. We can not 
ﬁ  nally exclude that the ﬁ  nal evolution of Patient one was 
precipitated by neuroleptic administration.
In patient 2, PE therapy was performed because of persis-
tent confusion and cardiac arrhythmia. The level of thyroxine 
in the extracted plasma was close to the one measured in the 
serum (352 pmol/L and 259 pmol/L respectively). Whereas 
the total T4 level decreased after the second PE, the free T4 
level rose concomitantly, and a clinical deterioration was 
observed. The level of plasma thyoxine-binding globulin 
(TBG) decreased after second PE, therefore raising, at least 
theoretically, the fraction of free thyroxine in the plasma. 
Fresh frozen plasma could be used as a substitute during 
PE, in order to supply thyroxin carriers and prevent any rise 
in free thyroxine levels, since 70% of thyroxine is bound 
to TBG, and 20%, to albumin. The clinical degradation 
after the second PE could have resulted from a rise in the free 
thyroxine level. However, clinical status has been reported 
to deteriorate between the 7th and 10th days after ingestion, 
while serum hormone levels are decreasing (Meurisse et al 
2000). This might reﬂ  ect that clinical status is more closely 
correlated to the effects of thyroid hormones at the cellular 
level, than at their circulating levels. This is in accordance 
with the evolution of patient 3, who had the highest level Therapeutics and Clinical Risk Management 2008:4(6) 1379
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of total thyroxine with only minor symptoms. The absence 
of link between the thyroid hormones levels and clinical 
symptoms has been reported (Nystrom et al 1980).
Patients 2 and 3 also received β blockers, hydrocortisone 
and cholestyramine (supposed to reduce thyroid hormones 
intestinal absorption ). Patient 2 was also given propylthio-
uracil on the ﬁ  rst day for its inhibition effect on T4 to T3 
conversion. Sodium ipodate is not available in France.
These observation suggest that thyroid hormone ingestion 
has to be suspected in any patient treated for obesity presenting 
with acute symptoms, especially confusion. Management 
should be based on the clinical symptoms and not on circulating 
hormone levels. When plasma exchange is considered, fresh 
frozen plasma should be used for substitution.
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